References
- Messas E, Goudot G, Halliday A, et al. Management of carotid stenosis for primary and secondary prevention of stroke: state-of-the-art 2020: a critical review. Eur Heart J Suppl. 2020;22(Suppl M):M35–M42. doi: 10.1093/eurheartj/suaa162
- Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H. Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med. 2014 Aug;5(8):927–946.
- Linton MF, Yancey PG, Davies SS, et al. The Role of Lipids and Lipoproteins in Atherosclerosis. In: Endotext (eds. Feingold KR et al.) MDText.com, Inc.: South Dartmouth, MA, USA, 2000.
- Ilhan F, Kalkanli ST. Atherosclerosis and the role of immune cells. World J Clin Cases. 2015 Apr 16;3(4):345–352. doi: 10.12998/wjcc.v3.i4.345
- Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022 Feb 22;145(8):e153–e639. doi: 10.1161/CIR.0000000000001052
- Geiger MA, Flumignan RLG, Sobreira ML, et al. Carotid Plaque Composition and the Importance of Non-Invasive in Imaging Stroke Prevention. Front Cardiovasc Med. 2022 May 16;9:885483. doi: 10.3389/fcvm.2022.885483
- GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20:795–820. doi: 10.1016/S1474-4422(21)00252-0
- Naylor R, Rantner B, Ancetti S, et al. Editor’s Choice - European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease. Eur J Vasc Endovasc Surg. 2023;65(1):7–111. doi: 10.1016/j.ejvs.2022.04.011
- Bonati LH, Kakkos S, Berkefeld J, et al. European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis. Eur Stroke J. 2021 Jun;6(2):I–XLVII. doi: 10.1177/23969873211012121
- Suphathamwit A, Leewatchararoongjaroen C, Rujirachun P, et al. Incidence of postoperative, major, adverse cardiac events in patients undergoing carotid endarterectomy: A single-center, retrospective study. SAGE Open Med. 2022 Jan 8;10:20503121211070367. doi: 10.1177/20503121211070367
- Reiff T, Eckstein HH, Mansmann U, et al. Carotid endarterectomy or stenting or best medical treatment alone for moderate-to-severe asymptomatic carotid artery stenosis: 5-year results of a multicentre, randomised controlled trial. Lancet Neurol. 2022;21:877–888. doi: 10.1016/S1474-4422(22)00290-3
- Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002 Nov 14;347(20):1557–1565. doi: 10.1056/NEJMoa021993
- Emerging Risk Factors Collaboration; Kaptoge S, Di Angelantonio E, Lowe G, et al. Pepys MB, Thompson SG, Collins R, Danesh J. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010 Jan 9;375(9709):132–140. doi: 10.1016/S0140-6736(09)61717-7
- Puz P, Lasek-Bal A, Ziaja D, Kazibutowska Z, Ziaja K. Inflammatory markers in patients with internal carotid artery stenosis. Arch Med Sci. 2013 Apr 20;9(2):254–260. doi: 10.5114/aoms.2013.34533
- Scimeca M, Montanaro M, Cardellini M, et al. High Sensitivity C-Reactive Protein Increases the Risk of Carotid Plaque Instability in Male Dyslipidemic Patients. Diagnostics (Basel). 2021 Nov 15;11(11):2117. doi: 10.3390/diagnostics11112117
- Rupprecht S, Finn S, Hoyer D, et al. Association Between Systemic Inflammation, Carotid Arteriosclerosis, and Autonomic Dysfunction. Transl Stroke Res. 2020 Feb;11(1):50–59. doi: 10.1007/s12975-019-00706-x
- Zhou F, Hua Y, Ji X, Jia L. A systemic review into carotid plaque features as predictors of restenosis after carotid endarterectomy. J Vasc Surg. 2021 Jun;73(6):2179–2188.e4. doi: 10.1016/j.jvs.2020.10.084
- Lusic I, Radonic V, Pavelin S, Bilic I. Is C-reactive protein a better predictor of recurrent carotid disease following carotid endarterectomy than established risk factors for atherosclerosis? Vasa. 2006 Nov;35(4):221–225. doi: 10.1024/0301-1526.35.4.221
- Schillinger M, Exner M, Mlekusch W, et al. Inflammation and Carotid Artery--Risk for Atherosclerosis Study (ICARAS). Circulation. 2005 May 3;111(17):2203–2209. doi: 10.1161/01.CIR.0000163569.97918.C0
- Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009 Jun;29(6):313–326. doi: 10.1089/jir.2008.0027
- Lin J, Kakkar V, Lu X. Impact of MCP-1 in atherosclerosis. Curr Pharm Des. 2014;20(28):4580–4588. doi: 10.2174/1381612820666140522115801
- Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest. 1991 Oct;88(4):1121–1127. doi: 10.1172/JCI115411
- Georgakis MK, Gill D, Rannikmäe K, et al. Genetically Determined Levels of Circulating Cytokines and Risk of Stroke. Circulation. 2019 Jan 8;139(2):256–268. doi: 10.1161/CIRCULATIONAHA.118.035905
- Georgakis MK, Malik R, Björkbacka H, et al. Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: Meta-Analysis of Population-Based Studies Involving 17180 Individuals. Circ Res. 2019 Sep 27;125(8):773–782. doi: 10.1161/CIRCRESAHA.119.315380. Erratum in: Circ Res. 2020 Jan 3;126(1):e9. doi: 10.1161/RES.0000000000000317
- Georgakis MK, de Lemos JA, Ayers C, et al. Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies. JAMA Cardiol. 2021 May 1;6(5):587–592. doi: 10.1001/jamacardio.2020.5392
- Nyárády BB, Dósa E, Kőhidai L, et al. Associations between Various Inflammatory Markers and Carotid Findings in a Voluntary Asymptomatic Population Sample. Int J Mol Sci. 2024 Sep 6;25(17):9656. doi: 10.3390/ijms25179656
- Nardi V, Di Venanzio L, Mahmoudi Hamidabad N, et al. Plasma cytokines are associated with major adverse cardiovascular events in follow-up of patients undergoing carotid endarterectomy. Eur Heart J. 2024;45(S1):ehae666.2292. doi: ehae666.2292
- Gaubatz JW, Ballantyne CM, Wasserman BA, et al. Association of circulating matrix metalloproteinases with carotid artery characteristics: the Atherosclerosis Risk in Communities Carotid MRI Study. Arterioscler Thromb Vasc Biol. 2010 May;30(5):1034–1042. doi: 10.1161/ATVBAHA.109.195370
- Kadoglou NP, Gerasimidis T, Moumtzouoglou A, et al. Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis. Eur J Vasc Endovasc Surg. 2008 Jun;35(6):661–668. doi: 10.1016/j.ejvs.2007.12.011
- Lahdentausta L, Leskelä J, Winkelmann A, et al. Serum MMP-9 Diagnostics, Prognostics, and Activation in Acute Coronary Syndrome and Its Recurrence. J Cardiovasc Transl Res. 2018;11(3):210–220. doi: 10.1007/s12265-018-9789-x
- Kadoglou N, Moulakakis KG, Mantas G, et al. Novel Biomarkers and Imaging Indices for the “Vulnerable Patient” with Carotid Stenosis: A Single-Center Study. Biomolecules. 2023;13(9):1427. doi: 10.3390/biom13091427
- Abilleira S, Bevan S, Markus HS. The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis. J Med Genet. 2006 Dec;43(12):897–901. doi: 10.1136/jmg.2006.040808
- Sigala F, Kotsinas A, Savari P, et al. Oxidized LDL in human carotid plaques is related to symptomatic carotid disease and lesion instability. J Vasc Surg. 2010;52:704–713. doi: 10.1016/j.jvs.2010.03.047
- Munjal A, Khandia R. Atherosclerosis: orchestrating cells and biomolecules involved in its activation and inhibition. Adv Protein Chem Struct Biol. 2020;120:85–122. doi: 10.1016/bs.apcsb.2019.11.002
- Dwivedi A, Anggård EE, Carrier MJ. Oxidized LDL-mediated monocyte adhesion to endothelial cells does not involve NFkappaB. Biochem Biophys Res Commun. 2001 Jun 1;284(1):239–244. doi: 10.1006/bbrc.2001.4955
- Woźniak A, Satała J, Gorzelak-Pabiś P, et al. OxLDL as a prognostic biomarker of plaque instability in patients qualified for carotid endarterectomy. J Cell Mol Med. 2024 Jul;28(14):e18459. doi: 10.1111/jcmm.18459
- Steyerberg EW, Harrell FE Jr. Prediction models need appropriate internal, internal-external, and external validation. J Clin Epidemiol. 2016 Jan;69:245–247. doi: 10.1016/j.jclinepi.2015.04.005
- Heinze G, Wallisch C, Dunkler D. Variable selection – A review and recommendations for the practicing statistician. Biom J. 2018 May;60(3):431–449. doi: 10.1002/bimj.201700067
- Orrapin S, Rerkasem K. Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev. 2017 Jun 7;6(6):CD001081. doi: 10.1002/14651858.CD001081.pub3. Update in: Cochrane Database Syst Rev. 2020 Sep 12;9:CD001081. doi: 10.1002/14651858.CD001081.pub4
- Balmos IA, Muresan MG, Brinzaniuc K, et al. Factors That Influence the Occurrence of Acute Postoperative Complications after Carotid Endarterectomy. Journal of Cardiovascular Emergencies. 2023;9(1):9–16. doi: 10.2478/jce-2023-0003
- Cruz Silva J, Constâncio V, Lima P, Anacleto G, Fonseca M. Effect of Chronic Antiplatelet and Anticoagulant Medication in Neck Hematoma and Perioperative Outcomes after Carotid Endarterectomy. Ann Vasc Surg. 2023 Jan;88:199–209. doi: 10.1016/j.avsg.2022.08.018
- Huibers A, de Borst GJ, Thomas DJ, Moll FL, Bulbulia R, Halliday A; ACST-1 Collaborative Group. The Mechanism of Procedural Stroke Following Carotid Endarterectomy within the Asymptomatic Carotid Surgery Trial 1. Cerebrovasc Dis. 2016;42(3–4):178–185. doi: 10.1159/000444651
- Molloy KJ, Thompson MM, Schwalbe EC, Bell PR, Naylor AR, Loftus IM. Elevation in plasma MMP-9 following carotid endarterectomy is associated with particulate cerebral embolisation. Eur J Vasc Endovasc Surg. 2004 Apr;27(4):409–413. doi: 10.1016/j.ejvs.2004.02.001
- Zielinska-Turek J, Dorobek M, Turek G, Barcikowska-Kotowicz M. MMP-9 and/or TIMP as predictors of ischaemic stroke in patients with symptomatic and asymptomatic atherosclerotic stenosis of carotid artery treated by stenting or endarterectomy - A review. Neurol Neurochir Pol. 2018 Sep–Oct;52(5):555–561. doi: 10.1016/j.pjnns.2018.05.005
- Heider P, Poppert H, Wolf O, et al. Fibrinogen and high-sensitive C-reactive protein as serologic predictors for perioperative cerebral microembolic lesions after carotid endarterectomy. J Vasc Surg. 2007 Sep;46(3):449–454. doi: 10.1016/j.jvs.2007.05.035
- Mack WJ, Ducruet AF, Hickman ZL, et al. Elevation of monocyte chemoattractant protein-1 in patients experiencing neurocognitive decline following carotid endarterectomy. Acta Neurochir (Wien). 2008 Aug;150(8):779–784; discussion 784. doi: 10.1007/s00701-008-1618-6